Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Spinnovation Introduces New Elemental and Trace Metals Analysis
Tuesday, November 05, 2013
New Elemental Analysis for cell culture media and raw materials.

Increasing the Safety of Biological Liquid Waste Disposal
Friday, November 01, 2013
New single-use waste collection bottles for Company’s VACUSIP system.

FEI Announces Release of ExSolve™
Thursday, October 31, 2013
ExSolve enables semiconductor and data storage manufacturers to obtain more information faster and at lower cost for process verification.

FEI Introduces the New Tecnai Femto Ultrafast Electron Microscope
Thursday, October 31, 2013
The Tecnai Femto is the first to commercialize revolutionary technology to investigate ultrafast events occurring at the nanometer femtosecond spatiotemporal scale.

New Method for Microcarrier Cell Culture using TAP’s ambr Micro Bioreactors
Thursday, October 31, 2013
Saves time optimizing process conditions enabling rapid vaccine production.

Leica TCS SP8 STED 3X - Fast and Direct 3D Super-resolution
Monday, October 28, 2013
See the full spectrum of life - with the smallest confocal volume ever.

Major Food Ingredients Firm Chr. Hansen Installs Fill-It™
Friday, October 25, 2013
To meet increasing demand for its high quality bacterial starter cultures.

New Webinar on Oncology Applications of RAFT 3D Cell Culture
Thursday, October 24, 2013
UCL and TAP Biosystems’ experts discuss 3D cell culture for effective cancer targeting.

Bulldog Bio Offers Tiny 3-D Imager for Live Cell Cytometry Analysis
Friday, October 18, 2013
Bulldog Bio awarded exclusive right to distribute their new compact microscope.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 190
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv